Cyrus Biotechnology, Inc. Sustainability Profile
Cyrus Biotechnology, Inc., commonly referred to as Cyrus Bio, is a pioneering company headquartered in the United States, with significant operations across various regions. Founded in 2014, Cyrus Bio operates at the intersection of biotechnology and computational science, specialising in protein design and engineering. The company is renowned for its innovative software solutions, particularly the Cyrus Bench platform, which streamlines the process of protein design, making it accessible and efficient for researchers and biopharmaceutical companies. With a strong focus on enhancing drug development and therapeutic applications, Cyrus Bio has established itself as a leader in the biotech industry, recognised for its unique approach to computational protein design. Through its commitment to advancing biotechnological research, Cyrus Bio continues to achieve notable milestones, solidifying its position as a key player in the evolving landscape of biotechnology.
DitchCarbon Score
How does Cyrus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cyrus Biotechnology, Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cyrus Biotechnology, Inc.'s reported carbon emissions
In 2023, Cyrus Biotechnology, Inc. reported no specific carbon emissions data, indicating a lack of disclosed Scope 1, 2, or 3 emissions figures. The company has not set any reduction targets or climate pledges, which suggests a need for further commitment to climate action. Cyrus Biotechnology's emissions data is not cascaded from any parent organisation, and there are no industry-standard climate initiatives such as SBTi or CDP targets associated with the company. As a result, the organisation currently lacks measurable climate commitments or significant reduction achievements. Overall, while Cyrus Biotechnology operates in a sector where climate accountability is increasingly vital, it appears to have yet to establish a clear framework for addressing its carbon footprint.
How Carbon Intensive is Cyrus Biotechnology, Inc.'s Industry?
How Carbon Intensive is Cyrus Biotechnology, Inc.'s Location?
Cyrus Biotechnology, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cyrus Biotechnology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
